BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
32964420
Number of visits today
6548
Number of downloads
16126796
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Peng H. Perspectives on the development of antibody-drug conjugates targeting ROR1 for hematological and solid cancers. Antib Ther 2021;4:222-7. [PMID: 34805745 DOI: 10.1093/abt/tbab023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Peng H, Nerreter T, Mestermann K, Wachter J, Chang J, Hudecek M, Rader C. ROR1-targeting switchable CAR-T cells for cancer therapy. Oncogene 2022. [PMID: 35859167 DOI: 10.1038/s41388-022-02416-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Yan Q, Fang X, Li C, Lan P, Guan X. Oncofetal proteins and cancer stem cells. Essays in Biochemistry 2022. [DOI: 10.1042/ebc20220025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sheyi R, de la Torre BG, Albericio F. Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate. Pharmaceutics 2022;14:396. [DOI: 10.3390/pharmaceutics14020396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345